Is Simulations Plus, Inc. (SLP) Halal?
Shariah Screening — 5 Standards
Based on financial data from August 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.3% / 30% | 13.1% / 30% | 3.9% / 30% | 0.91% / 5% | ✓ HALAL |
| DJIM | 0.3% / 33% | 13.1% / 33% | 3.9% / 33% | 0.91% / 5% | ✓ HALAL |
| MSCI | 0.5% / 33% | 24.5% / 33% | 7.4% / 33% | 0.91% / 5% | ✓ HALAL |
| S&P | 0.3% / 33% | 13.1% / 33% | 3.9% / 33% | 0.91% / 5% | ✓ HALAL |
| FTSE | 0.5% / 33% | 24.5% / 33% | 7.4% / 50% | 0.91% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 59.6% | |
| Operating Margin | 3.9% | |
| Net Margin | -81.7% | |
| Return on Equity (ROE) | -41.2% | |
| Return on Assets (ROA) | 2.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $18M |
| Free Cash Flow | $14M |
| Total Debt | $616,000 |
| Debt-to-Equity | 0.4 |
| Current Ratio | 5.6 |
| Total Assets | $132M |
Price & Trading
| Last Close | $11.70 |
| 50-Day MA | $14.08 |
| 200-Day MA | $15.85 |
| Avg Volume | 322K |
| Beta | 1.2 |
|
52-Week Range
$11.16
| |
About Simulations Plus, Inc. (SLP)
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Purification Calculator
As a halal stock with 0.91% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Simulations Plus, Inc. (SLP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Simulations Plus, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Simulations Plus, Inc.'s debt ratio?
Simulations Plus, Inc.'s debt ratio is 0.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.5%.
Does Simulations Plus, Inc. require dividend purification?
Yes, Simulations Plus, Inc. has an impermissible income ratio of 0.91%, which means 0.91% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Simulations Plus, Inc.'s key financial metrics?
Simulations Plus, Inc. has a market capitalization of $230M, and revenue of $79M. The company maintains a gross margin of 59.6% and a net margin of -81.7%. Return on equity stands at -41.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.